Filing Details

Accession Number:
0001437749-17-012172
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-07-03 16:17:19
Reporting Period:
2017-06-29
Filing Date:
2017-07-03
Accepted Time:
2017-07-03 16:17:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
810509 Navidea Biopharmaceuticals Inc. NAVB In Vitro & In Vivo Diagnostic Substances (2835) 311080091
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1559381 J. William Regan 4995 Bradenton Ave., Suite 240
Dublin OH 43017
Svp & Cco No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-06-29 20,000 $0.53 172,977 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct